Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be...
Pantoprazole Injection:
Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis
...
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
IWK Health Centre, Halifax, Nova Scotia, Canada
McMaster Children's Hospital, Hamilton, Ontario, Canada
Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
Site RU70008, Saint-Petersburg, Russian Federation
Site RU70012, Saint-Petersburg, Russian Federation
Site RU70013, Volgograd, Russian Federation
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung, Taiwan
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
Dept. of Intensive Care Medicine, University of Bern,, Bern, Switzerland
Rigshospitalet, Copenhagen, Denmark
Clinic for psychiatric disorders Dr Laza Lazarevic, Belgrade, Serbia
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.